Connect your AI

Medifast MED Remainder of Fiscal Year 2024

Remainder of Fiscal Year 2024 at other companies

Lifevantage CorporationLFVN

——

Other financials

Income statement

Revenue$76.0M-34.3%

Gross profit$51.8M-38.6%

Operating income-$3.3M-161%

Net income-$2.1M-175%

EPS (diluted)-$0.19-171%

Balance sheet

Cash & equivalents$71.5M-22.0%

Total debt$16.1M+10.2%

Total equity$197.7M-6.3%

Total assets$252.0M-10.0%

Cash flow

Operating cash flow$260.0K-92.4%

CapEx$1.1M-28.0%

Free cash flow-$836.0K-144%

Valuation

Market cap$121.87M-17.4%

Enterprise value$66.44M+12.8%

P/S0.4×0.0×

Profitability

Gross margin70.1%-3.8pp

Operating margin-4.7%-7.0pp

Net margin-5.8%-8.1pp

FCF margin5%-9.3pp

Returns & leverage

Return on equity-9.8%-20.1pp

Debt / equity0.1×0.0×

Current ratio4.8×+1.3×

Where this comes from

Reported directly by Medifast in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear.

The official record: Medifast’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Medifast's remainder of fiscal year 2024.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Medifast's remainder of fiscal year 2024?: Medifast (MED) reported remainder of fiscal year 2024 of $3.51M in Q1 2026.
How has Medifast's remainder of fiscal year 2024 changed year-over-year?: Medifast's remainder of fiscal year 2024 decreased by 27.7% year-over-year, from $4.86M to $3.51M.